Safety

Safety, Risks, and Contraindications

Ketamine therapy is a real medical intervention with real risks. Reading honestly about those risks is the first responsible step.

Written by: Ira ZootMedical review status: Pending clinical reviewLast updated: May 18, 2026Evidence: Safety review

This page is the general risk and adverse-effect reference: what can go wrong, what is contraindicated, and why supervision matters. Candidacy and screening are handled separately, and clinician-facing questions live in the provider checklist.

Related on Ketalux

Quick answer

Is ketamine therapy safe?

In supervised medical settings with proper screening, monitoring, and dosing, ketamine has a well-characterized short-term safety profile. Risks concentrate in three areas: cardiovascular strain (elevated blood pressure and heart rate), psychological effects (dissociation, rare persistent perceptual changes), and misuse potential with unsupervised or high-frequency dosing. It is not safe for everyone - active psychosis, uncontrolled hypertension, and certain substance use disorders are common contraindications.

Key takeaways

Most common short-term effects: transient blood pressure and heart rate elevation, nausea, dissociation, and dizziness.
Cardiovascular screening is required — uncontrolled hypertension or unstable heart disease is a contraindication.
Frequent, high-dose recreational use is linked to bladder toxicity (ketamine cystitis); therapeutic protocols are far below that exposure but not risk-free.
Psychological risk is highest with unsupervised at-home use and in people with psychotic-spectrum illness.
Safety hinges on medical screening, monitored dosing, informed consent, and integration — not on the molecule alone.

Read this first

This page is not exhaustive. It does not replace a clinician's screening, informed consent discussion, or your responsibility to disclose your full medical history. If you're in crisis, contact 988 (US) or your local emergency services.

Common short-term effects

Dissociation and altered perception during dosing
Transient increases in blood pressure and heart rate
Nausea, dizziness, or coordination changes
Emotional intensity, including unexpected memories or affect

Less common but serious considerations

Cardiovascular strain in people with underlying conditions
Urinary tract toxicity with frequent or high-dose use
Persistent perceptual changes in rare cases
Psychological dependence with unsupervised use

Less likely

More likely →

↑ More severe

Transient dissociation

Nausea / dizziness

Elevated BP / HR

Emotional intensity

Psychological dependence

Urinary toxicity (frequent use)

Persistent perceptual changes

Illustrative risk landscape - not a clinical scoring tool.

Contraindications and cautions

People with uncontrolled hypertension, certain cardiovascular disease, active psychotic disorders, certain substance use disorders, pregnancy, or specific other conditions may not be appropriate candidates. Some medications interact meaningfully with ketamine. A complete screening is essential.

Phase 1
Pre-dose
Baseline vitals, consent, setting
Phase 2
Onset
Dose administered, monitoring begins
Phase 3
Peak
Dissociation, BP/HR closely tracked
Phase 4
Wind-down
Effects subside, vitals re-checked
Phase 5
Discharge
Aftercare plan, integration scheduled

A responsible supervised session has clearly defined phases and active monitoring throughout.

The role of supervision

Medical supervision is not a formality. It exists to monitor vital signs, manage adverse reactions, support psychological safety, and ensure dosing remains appropriate. Programs that minimize supervision or screening warrant skepticism.

Limits of current research

Long-term safety data, optimal dosing schedules, and use in adolescents, older adults, and pregnancy are areas where evidence remains limited. Responsible programs acknowledge these gaps rather than minimizing them.

Frequently asked questions

Who should not use ketamine therapy?+

People with uncontrolled hypertension or cardiovascular disease, active psychosis, certain substance use disorders, pregnancy, and specific other medical conditions may not be suitable candidates. A qualified clinician should perform a full medical and psychiatric screening.

Can ketamine be addictive?+

Ketamine has known abuse potential and can lead to psychological dependence, particularly with unsupervised, frequent, or high-dose use. Supervised medical protocols are designed to mitigate this risk, but it should not be ignored.

What are common side effects?+

Common transient effects include dissociation, dizziness, nausea, elevated blood pressure and heart rate, and emotional intensity. Most resolve within hours, but rare serious effects exist and warrant medical monitoring.

References

Spravato (esketamine) prescribing information and REMS program. U.S. Food and Drug Administration Regulatory
Short RE et al. — Side-effects associated with ketamine use in depression: a systematic review. The Lancet Psychiatry / PubMed · 2018 Meta-analysis
Sanacora G et al. — Consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry / PubMed · 2017 Guideline
Morgan CJA, Curran HV — Ketamine use: a review (cognitive and urinary tract effects). Addiction / PubMed · 2012 Review